From May 8th to 11th, BIOEMTECH participated in the 17th Panhellenic & 12th Balkan Congress of Nuclear Medicine, held at the War Museum in Athens, Greece. The event brought together experts from Greece and the wider Balkan region, highlighting developments in diagnostic and therapeutic applications of nuclear medicine.
During the congress, our Chief Business Officer, Maritina Rouchota, delivered an oral presentation titled: “²²⁵Ac Imaging: A key to advancing biodistribution assessment in targeted alpha therapy.”
This presentation focused on the growing importance of imaging tools in the evaluation of radiopharmaceuticals labeled with alpha emitters like ²²⁵Ac, a critical step in the development of effective and safe targeted alpha therapies.
We are always proud to contribute to scientific dialogue and collaborate with the nuclear medicine community.